Seroprevalence of the Anti-SARS-CoV-2 Antibodies (Causing COVID-19) in Kidney Transplant Recipients in Severely Affected Region
Clinical trial NCT04874740 · COMPLETED
Trial details
- NCT number
- NCT04874740
- Sponsor
- University Hospital Ostrava
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-30
- Primary completion
- 2022-10-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.